Pollution Related Respiratory Disorder
8
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
25%
2 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases
Solar Lighting to Reduce Indoor Air Pollution in Rural Uganda
Effectiveness of Low-Dose Theophylline for the Management of Biomass-Associated COPD
Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure
Towards Life-Long Healthy Lungs: A Multidisciplinary Follow-up Framework for Preterm Infants
Innate Immunity in Ozone-induced Airway Inflammation in COPD
Impact of Pollution on Allergic Rhinitis and Sleep Quality: the POLLAR Study
Behavioral Research of Environment and Air Pollution Through Education